Skip to main content
Dryad logo

Data from: Differential impacts of vaccination on wildlife disease spread during epizootic and enzootic phases

Citation

Newton, Erica J. et al. (2019), Data from: Differential impacts of vaccination on wildlife disease spread during epizootic and enzootic phases, Dryad, Dataset, https://doi.org/10.5061/dryad.97tt75g

Abstract

1. Dissemination of oral vaccine baits is a cost-effective method to contain and control infectious wildlife diseases. The effectiveness of vaccine barriers in slowing or halting the disease spread depends on host ecology and landscape variability. It is not clear, however, how the success of vaccine barriers to manage disease may change from an epizootic to an enzootic phase of a disease invasion, and if this depends on the quality and configuration of host habitat. 2. We explore these questions using the raccoon variant rabies virus (RRV) as a model system. This zoonotic disease of high concern has been enzootic in eastern North America for decades, pushing into new areas and re-emerging in previously controlled zones. 3. We use a spatially-explicit individual-based model to assess how levels of oral vaccination and habitat fragmentation affect RRV spread across vaccine barriers during epizootic and enzootic phases. Simulated outcomes are compared using space-time characteristics of infection chains (individual-to-individual transmission of RRV). 4. Results indicate that the impact of vaccine barriers on control of RRV is strongest during the epizootic phase. Counterproductively, mid-levels of immunisation during an enzootic phase lead to more rabies-induced mortalities than lower or higher vaccination levels. Infection chains spread faster during the epizootic phase. Landscape effects on chain characteristics were more subtle than effects of invasion phase and vaccination. 5. Synthesis and applications. Space-time patterns of infection chains provide insight into mechanisms of wildlife disease spread. Our results demonstrate the importance of detecting and controlling outbreaks before they become enzootic. We discuss the implications for moving vaccine barriers to push back and decrease the size of enzootic areas.

Usage Notes